May 16, 2011
Xanodyne Pharmaceuticals Appoints New Chief Operating Officer
May 27, 2010
XANODYNE ANNOUNCES PLANNED PRESIDENT & CEO SUCCESSION
May 7, 2010
XANODYNE ANNOUNCES RENEWED FOCUS ON PAIN MANAGEMENT MARKET
[ Corporate Governance ]
Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management.
Key Promoted Product: Zipsor® for the treatment of mild to moderate acute pain in adults was approved by the FDA on June 16, 2009.
Zipsor® is the first liquid filled capsule NSAID with ProSorb® technology indicated for mild to moderate acute pain in adults (18 years or older)... [MORE]
